erythromycin has been researched along with Alveolitis, Fibrosing in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (38.89) | 18.7374 |
| 1990's | 8 (44.44) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FASSIO, PG; VISCO, G | 1 |
| Aoyama, S; Azuma, A; Kudo, S; Matsuda, K; Omura, T; Shirokine, J; Sunazuka, T | 1 |
| Abe, S; Azuma, A; Hirata, Y; Inagaki, H; Kawada, T; Kudoh, S; Li, YJ; Matsuda, K; Omura, S; Shimizu, T; Sunazuka, T; Takahashi, S; Usuki, J | 1 |
| Aono, Y; Azuma, M; Inayama, M; Izumi, K; Kinoshita, K; Kishi, J; Makino, H; Nishioka, Y; Ogushi, F; Shono, M; Sone, S; Uehara, H | 1 |
| Couvreur, J; Garcia, J; Tournier, G | 1 |
| Eben-Moussi, E; N'Kam, M; Petitpretz, P; Regnier, B; Vachon, F; Wolff, M | 1 |
| Chen, B; Hou, XM; Jiang, L; Yu, R; Zhao, W | 1 |
| Alujević, A; Andjelinović, S; Janković, S; Marasović, D; Mise, K; Tocilj, J | 1 |
| Aktoğu, S; Değirmenci, B; Dereli, S; Durak, H; Ertay, T; Sayit, E | 1 |
| He, B; Li, Y; Wang, H | 1 |
| Chen, J; He, B; Li, Y; Wang, G; Zhang, W | 1 |
| He, B; Liu, X; Tan, W; Xu, S | 1 |
| Beem, MO; Saxon, E; Tipple, MA | 1 |
| Brower, S; Browne, MJ; Cotton, D; Gill, V; Glatstein, E; Gress, J; Hathorn, J; Hiemenz, J; Potter, D; Thaler, M | 1 |
| Hürter, T; Lorenz, J; Rumpelt, HJ; Schlegel, J | 1 |
| Basset, F; Brun, P; Chastre, J; Gibert, C; Raghu, G; Soler, P | 1 |
| Dehan, M; Gabilan, JC; Magny, JF; Ropert, JC; Saby, MA; Zouari, A | 1 |
| Reyes, MP; Tablan, OC | 1 |
1 trial(s) available for erythromycin and Alveolitis, Fibrosing
| Article | Year |
|---|---|
A randomized trial of open lung biopsy versus empiric antimicrobial therapy in cancer patients with diffuse pulmonary infiltrates.
Topics: Adult; Agranulocytosis; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Neoplasms; Pneumonia, Pneumocystis; Prospective Studies; Pulmonary Fibrosis; Random Allocation; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
17 other study(ies) available for erythromycin and Alveolitis, Fibrosing
| Article | Year |
|---|---|
[PNEUMONIA].
Topics: Adenoviridae Infections; Anti-Bacterial Agents; Bronchopneumonia; Child; Cortisone; Erythromycin; Humans; Infant; Influenza, Human; Penicillins; Plasma Cells; Pneumonia; Pneumonia, Pneumocystis; Pneumonia, Rickettsial; Pneumonia, Viral; Psittacosis; Pulmonary Fibrosis; Q Fever; Streptomycin; Tetracycline | 1963 |
[Action of EM703 on bleomycin-induced pulmonary fibrosis in mice].
Topics: Animals; Anti-Inflammatory Agents; Bleomycin; Bronchoalveolar Lavage Fluid; Collagen; Erythromycin; Hydroxyproline; Lung; Male; Mice; Mice, Inbred ICR; Pulmonary Fibrosis | 2004 |
EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Topics: Animals; Anti-Inflammatory Agents; Base Sequence; Bleomycin; Cell Line; Cell Proliferation; Collagen; Dose-Response Relationship, Drug; Erythromycin; Fibroblasts; Gene Expression Regulation; Hydroxyproline; Lung; Male; Mice; Mice, Inbred ICR; Molecular Sequence Data; Pulmonary Fibrosis; Smad2 Protein; Smad3 Protein; Smad4 Protein; Transforming Growth Factor beta | 2006 |
Role of alpha1-acid glycoprotein in therapeutic antifibrotic effects of imatinib with macrolides in mice.
Topics: Animals; Benzamides; Cells, Cultured; Clarithromycin; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Fibroblasts; Imatinib Mesylate; Macrolides; Mice; Orosomucoid; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines | 2007 |
[Chlamydia trachomatis pneumopathies in infants].
Topics: Antibodies, Bacterial; Chlamydia Infections; Chlamydia trachomatis; Drug Therapy, Combination; Erythromycin; Humans; Infant; Infant, Newborn; Pulmonary Fibrosis; Sulfisoxazole | 1984 |
[Psittacosis as a cause of acute respiratory distress syndrome (author's transl)].
Topics: Adult; Diagnosis, Differential; Erythromycin; Female; Humans; Lung; Male; Pneumonia; Psittacosis; Pulmonary Fibrosis; Radiography; Respiratory Distress Syndrome; Serologic Tests | 1982 |
Ameliorating effect of erythromycin on bleomycin-induced pulmonary fibrosis: role of alveolar macrophage activation and cytokine release.
Topics: Animals; Anti-Bacterial Agents; Bleomycin; Bronchoalveolar Lavage Fluid; Cells, Cultured; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Erythromycin; Female; Hydroxyproline; Lung; Macrophage Activation; Macrophages, Alveolar; Platelet-Derived Growth Factor; Pulmonary Fibrosis; Rats; Rats, Wistar; Reference Values; Tumor Necrosis Factor-alpha | 1997 |
A case of syphilitic interstitial pulmonary fibrosis.
Topics: Aged; Anti-Bacterial Agents; Disease Progression; Erythromycin; Fatal Outcome; Female; Humans; Pulmonary Fibrosis; Syphilis Serodiagnosis; Syphilis, Latent; Treponema pallidum | 1998 |
Tc-99m erythromycin lactobionate inhalation scintigraphy in parenchymal lung diseases.
Topics: Administration, Inhalation; Adult; Aged; Erythromycin; Female; Half-Life; Humans; Lung; Lung Diseases; Male; Middle Aged; Organotechnetium Compounds; Pulmonary Fibrosis; Radionuclide Imaging; Radiopharmaceuticals; Respiratory Function Tests; Sarcoidosis; Tuberculosis, Pulmonary | 1999 |
[The effect of erythromycin on NF-kappa B activation and cytokines mRNA expression in bleomycin-induced pulmonary fibrosis in rats].
Topics: Animals; Anti-Bacterial Agents; Bleomycin; Cytokines; Disease Models, Animal; Erythromycin; Gene Expression; Interleukin-1; Male; NF-kappa B; Pulmonary Fibrosis; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta | 1999 |
[An experimental study on the effect of azithromycin treatment in bleomycin-induced pulmonary fibrosis of rats].
Topics: Animals; Anti-Bacterial Agents; Bleomycin; Erythromycin; Male; NF-kappa B; Pulmonary Fibrosis; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 1999 |
[The mechanism and effect of erythromycin in development of pulmonary fibrosis].
Topics: Animals; Anti-Bacterial Agents; Collagen; Erythromycin; Macrophages; Male; Pulmonary Fibrosis; Rats; Rats, Wistar; RNA, Messenger; Tumor Necrosis Factor-alpha | 1999 |
Treatment of chlamydial pneumonia of infancy.
Topics: Chlamydia trachomatis; Chlamydiaceae Infections; Erythromycin; Humans; Infant; Infant, Newborn; Length of Stay; Nasopharynx; Oxygen Inhalation Therapy; Physical Therapy Modalities; Pneumonia; Pulmonary Fibrosis; Sulfisoxazole | 1979 |
[Persisting alveolitis after Legionella pneumonia].
Topics: Adult; Antibodies, Bacterial; Biopsy; Chronic Disease; Drug Therapy, Combination; Erythromycin; Humans; Legionella; Legionnaires' Disease; Lung; Male; Middle Aged; Prednisone; Pulmonary Fibrosis | 1990 |
Pulmonary fibrosis following pneumonia due to acute Legionnaires' disease. Clinical, ultrastructural, and immunofluorescent study.
Topics: Adult; Aged; Basement Membrane; Erythromycin; Female; Fluorescent Antibody Technique; Humans; Legionnaires' Disease; Male; Middle Aged; Pneumonia; Pulmonary Fibrosis; Rifampin | 1987 |
[Apnea disclosing Chlamydia trachomatis infection in a premature infant].
Topics: Apnea; Bradycardia; Chlamydia Infections; Chlamydia trachomatis; Erythromycin; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Pulmonary Fibrosis; Trachea | 1986 |
Chronic interstitial pulmonary fibrosis following Mycoplasma pneumoniae pneumonia.
Topics: Adult; Dyspnea; Erythromycin; Female; Humans; Pneumonia, Mycoplasma; Prednisone; Pulmonary Fibrosis | 1985 |